Welcome to the world of immunohistochemistry!
📞 800-8581156 📧 info@naim.com.cn
Menu
  • Home
  • Product
  • Service and Support
    • Immunohistochemistry and Pathology
    • Immunohistochemistry Technology Exchange
    • Recommended List and Introduction of Newly Developed IHC
    • Public laboratory
    • Consultation and Feedback
  • News and Information
    • Hotspot Focus
    • Industry News
    • Maxxin Dynamics
    • Meeting Notice
  • Entering Maixin
    • Corporate Culture
    • Maisin Honors
    • Maixin Company Profile
    • Myriad Pathology Foundation Overview
  • Contact us
Close
分类
  • Consultation and Feedback
  • Hotspot Focus
  • Immunohistochemistry and Pathology
  • Immunohistochemistry Technology Exchange
  • Industry News
  • Maxxin Dynamics
  • Meeting Notice
  • News and Information
  • Public laboratory
  • Recommended List and Introduction of Newly Developed IHC
  • Service and Support
  • Uncategorized
Product Search
06 2 月
Industry News
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Chinese Doctors’ Day • Saluting You, the Guardians of Life

Preface:After the summer heat waves, early autumn quietly arrives. In this golden breeze and refreshing early autumn season, we welcome...
Continue reading
06 2 月
Industry News
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Chronic H. pylori Infection Classified as a “Definite Carcinogen”: Maxin’s HP Antibody Aids Scientific Prevention and Control!

Introduction:The incidence of gastric cancer ranks fifth among known cancers worldwide. In China, due to dietary habits, it is among th...
Continue reading
06 2 月
Industry News
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

2015 Immunohistochemistry Technology Theory and Application Training Successfully Concluded

To enhance the fundamental theory and application level of immunohistochemistry among medical institutions in Beijing and pathological ...
Continue reading
06 2 月
Industry News
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Heroes Return, Welcome Home!

Introduction:Starting from March 17th, medical personnel from all over the country who supported Hubei began to withdraw in batches. To...
Continue reading
06 2 月
Industry News
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Minutes of the 10th Anniversary Celebration Meeting of the Beijing Pathology Technology Group

The 5th Technical Academic Annual Conference of the Pathology Professional Committee of the Beijing Branch of the Chinese Medical Assoc...
Continue reading
06 2 月
Industry News
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Gathering in Guang’an, Discussing Pathology—A Direct Look at the Successful Opening of the 2016 Western Outreach of the Chinese Society of Pathology and the Chongqing Society of Pathology Annual Academic Conference

      To further promote the development of pathology in the western region and strengthen academic exchanges and c...
Continue reading
06 2 月
Industry News
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Countdown 7 Days | Join Us at the Maxin Special Satellite Meeting!

Continue reading
06 2 月
Industry News
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

In the Era of Precision Medicine, the Importance of Pathological Diagnosis is Highlighted—Latest “Clinical Rational Use Management Indicators for Antitumor Drugs” Released

Introduction:On June 28, 2021, to implement the "Administrative Measures for Clinical Application of Antineoplastic Drugs (Trial)" (Nat...
Continue reading
06 2 月
Industry News
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Policy Boost | Government Subsidized Medical Equipment Upgrade Projects, Maxim’s Comprehensive and Integrated Pathology Solutions Facilitate New Developments in Pathology Discipline

Introduction:Recently, the National Health Commission issued the "Notice on the Implementation of Fiscal Discount Loans for Upgrading a...
Continue reading
  • 1
  • 2
  • 3
  • 4
  • 5

Copyright © 1993 - 2017 Fuzhou Maixin Biotechnology Development Co., Ltd. MinICP No. 05015562-1 | (Fujian) - Non-commercial - 2017-0010

  • Home
  • Product
  • Service and Support
    • Immunohistochemistry and Pathology
    • Immunohistochemistry Technology Exchange
    • Recommended List and Introduction of Newly Developed IHC
    • Public laboratory
    • Consultation and Feedback
  • News and Information
    • Hotspot Focus
    • Industry News
    • Maxxin Dynamics
    • Meeting Notice
  • Entering Maixin
    • Corporate Culture
    • Maisin Honors
    • Maixin Company Profile
    • Myriad Pathology Foundation Overview
  • Contact us
Sidebar